We hypothesize that (1) in Aβ‐positive individuals, Hcy potentiates tau‐mediated neurodegeneration and accelerates cortical thinning and cognitive impairment through Aβ–tau synergism and vascular mechanisms. The gene discussed is MAPT; the disease is Cognitive impairment.